Breathe BioMedical is developing a non-invasive breath test to detect early-stage breast cancer. Our focus is to build on our proof of concept study (81.4% accuracy) to commercialize a breath test for women with dense breast tissue.
Breathe BioMedical is developing a non-invasive breath test to detect early-stage breast cancer. Our focus is to build on our proof of concept study (81.4% accuracy) to commercialize a breath test for women with dense breast tissue.
Femtech Canada would like to respectfully acknowledge the historical oppression of lands, cultures and the original peoples in what we now know as Canada. We recognize that we must do more to learn about the rich history of this land so that we can better understand our roles as residents, neighbors, partners and caretakers.
Our website uses cookies to ensure you get the best experience. Learn More